BioAtla, Inc. Common Stock (NASDAQ: BCAB) last traded at $1.28, up 2.40% on the session. The quote above updates while this page is open; the figures below are drawn from BioAtla, Inc. Common Stock’s own filings and are restated only when a new one is published.
BioAtla, Inc. Common Stock trades on NASDAQ under the ticker BCAB. Its market capitalisation is $2.13 million.
Valuation measures for BioAtla, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.13M |
|---|---|
| Enterprise value | $46.33M |
| P/E ratio | 0.05 |
| Beta | 0.20 |
Trailing-twelve-month figures tagged in BioAtla, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$31.45M |
| EPS (TTM) | $24.19 |
|---|
| Cash | $1.54M |
|---|
Range and volume for BCAB over the past 52 weeks.
| 52-week high | $71.50 |
|---|---|
| 52-week low | $1.07 |
| Volume | 11.2K |
| Average volume | 58.7K |
| Previous close | $1.25 |
Invest a chosen dollar amount in BioAtla, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BCAB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.